Could the IPO window really be reopening for the summer? The second biotech proposition in May suggests that the public ...

Actuate Therapeutics (ACTU), which is working on a treatment for pancreatic cancer, has filed for a proposed $50M initial public offering. The company didn’t disclose terms in its SEC filing, but ...

Actuate intends to list its common stock on the Nasdaq Capital Market under the symbol “ACTU”. Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager and ...

Actuate Therapeutics, Inc. files for $50M IPO to support its pioneering treatments for pancreatic and other cancers. Click here for a look at the upcoming ACTU IPO.

The light actuation force of mechanical keys reduces the need for heavy pressing on gaming keys. Mechanical keyboards offer ...

By Dean Seal Actuate Therapeutics has filed for an initial public offering on the Nasdaq Capital Market. The clinical stage biopharmaceutical company ...

A new crop of early-stage startups — along with some recent VC investments — illustrates a niche emerging in the autonomous ...

Pakistan has finally reached the pass where the federal budget for the financial year 2024-25 will test the waters: whether ...

The deal is J&J’s second this month involving bispecific antibodies, a technology the company has prioritized to build its immune and cancer drug pipeline.

The long-awaited Porsche 911 hybrid has been revealed alongside a wider update across the iconic sports car range. Now in its ...

This mobile missile performs with an amazing level of precision. Even at low speeds, it effortlessly and controllably ...

We road-test all this year’s best electric bikes, from folding Bromptons to family-friendly Raleighs and Swytchbike ...